Glenmark Pharmaceuticals

Drug Development

How Glenmark’s AbbVie Deal is a Masterclass in Indian Pharma's R&D Ambitions

BY Vaibhavi Ranjan

Glenmark signs landmark licensing deal

Glenmark Pharma Shares Surge 10% On Arm’s Landmark Deal with AbbVie For Cancer Drug

BY Outlook Business Desk

Glenmark to Pay $7 Million to Settle Lawsuits with Three Entities in US

Glenmark to Pay $7 Million to Settle Lawsuits with Three Entities in US

BY PTI

Glenmark To Pay $87.5 Millon To Settle Lawsuits Over A Product In US

Glenmark To Pay $87.5 Millon To Settle Lawsuits Over A Product In US

BY Press Trust of India

Glenmark Pharmaceuticals Get USFDA Nod For Human Trial Of Advanced Cancer-Treating Drug

Glenmark Pharmaceuticals Get USFDA Nod For Human Trial Of Advanced Cancer-Treating Drug

BY Press Trust of India

Glenmark And Cediprof Announce Exclusive Distribution Agreement In US

Glenmark And Cediprof Announce Exclusive Distribution Agreement In US

BY Press Trust of India

Glenmark Gets USFDA Nod For Generic Diabetes Drug

Glenmark Gets USFDA Nod For Generic Diabetes Drug

BY Press Trust of India

Advertisement

USFDA Gives Exception To Glenmark Pharma To Supply Pneumonia Drug From Baddi Facility

USFDA Gives Exception To Glenmark Pharma To Supply Pneumonia Drug From Baddi Facility

BY Press Trust of India

Glenmark Pharma

USFDA Issues Import Alert On Glenmark Pharma's Baddi Plant

BY Press Trust of India

These are generic versions of Vimpat tablets of the corresponding strengths of UCB, Inc.

Glenmark Pharmaceuticals Gets USFDA Nod For Lacosamide Tablet

BY Press Trust of India

Limited Upside for Glenmark Pharmaceuticals

Limited Upside for Glenmark Pharmaceuticals